Revolution Medicines, Inc.
RVMD
$40.78
-$1.10-2.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.69% | -24.49% | -17.30% | -14.85% | 28.19% |
| Total Depreciation and Amortization | 10.66% | 19.79% | -0.77% | 5.44% | -3.71% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 50.00% | -33.33% | 0.00% |
| Total Other Non-Cash Items | 17.99% | -14.08% | 80.53% | 6,650.47% | -100.63% |
| Change in Net Operating Assets | -94.20% | 306.42% | 318.12% | 89.96% | -323.17% |
| Cash from Operations | -40.60% | -6.04% | -1.76% | 20.18% | -33.18% |
| Capital Expenditure | -167.27% | 65.28% | -46.73% | 24.25% | -36.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.76% | -2,082.19% | -116.27% | 145.07% | 35.25% |
| Cash from Investing | 95.94% | -1,730.09% | -119.89% | 143.53% | 34.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.89% | 906.67% | 930.04% | 826.42% | -68.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.02% | -- | -- | -- | -- |
| Cash from Financing | -99.90% | 1,030.50% | 930.04% | 826.42% | -99.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.15% | 559.30% | -486.48% | 96.88% | -220.49% |